Acute intermittent porphyria: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 48: Line 48:
{{MedCondContrAbs
{{MedCondContrAbs


|MedCond = History of acute intermittent porphyria|Carisoprodol}}
|MedCond = History of acute intermittent porphyria|Carisoprodol|[[Meprobamate]]}}


==Famous sufferers==
==Famous sufferers==

Revision as of 17:25, 19 January 2015

Acute intermittent porphyria
ICD-10 E80.2
ICD-9 277.1
OMIM 176000
DiseasesDB 171
eMedicine med/1880 
MeSH D017118

WikiDoc Resources for Acute intermittent porphyria

Articles

Most recent articles on Acute intermittent porphyria

Most cited articles on Acute intermittent porphyria

Review articles on Acute intermittent porphyria

Articles on Acute intermittent porphyria in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Acute intermittent porphyria

Images of Acute intermittent porphyria

Photos of Acute intermittent porphyria

Podcasts & MP3s on Acute intermittent porphyria

Videos on Acute intermittent porphyria

Evidence Based Medicine

Cochrane Collaboration on Acute intermittent porphyria

Bandolier on Acute intermittent porphyria

TRIP on Acute intermittent porphyria

Clinical Trials

Ongoing Trials on Acute intermittent porphyria at Clinical Trials.gov

Trial results on Acute intermittent porphyria

Clinical Trials on Acute intermittent porphyria at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Acute intermittent porphyria

NICE Guidance on Acute intermittent porphyria

NHS PRODIGY Guidance

FDA on Acute intermittent porphyria

CDC on Acute intermittent porphyria

Books

Books on Acute intermittent porphyria

News

Acute intermittent porphyria in the news

Be alerted to news on Acute intermittent porphyria

News trends on Acute intermittent porphyria

Commentary

Blogs on Acute intermittent porphyria

Definitions

Definitions of Acute intermittent porphyria

Patient Resources / Community

Patient resources on Acute intermittent porphyria

Discussion groups on Acute intermittent porphyria

Patient Handouts on Acute intermittent porphyria

Directions to Hospitals Treating Acute intermittent porphyria

Risk calculators and risk factors for Acute intermittent porphyria

Healthcare Provider Resources

Symptoms of Acute intermittent porphyria

Causes & Risk Factors for Acute intermittent porphyria

Diagnostic studies for Acute intermittent porphyria

Treatment of Acute intermittent porphyria

Continuing Medical Education (CME)

CME Programs on Acute intermittent porphyria

International

Acute intermittent porphyria en Espanol

Acute intermittent porphyria en Francais

Business

Acute intermittent porphyria in the Marketplace

Patents on Acute intermittent porphyria

Experimental / Informatics

List of terms related to Acute intermittent porphyria

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]


Acute intermittent porphyria (AIP) is a rare metabolic disorder in the production of heme, the oxygen-binding prosthetic group of hemoglobin. Specifically, it is characterized by a deficiency of the enzyme porphobilinogen deaminase.

Mechanism of disease

Normally, heme synthesis begins in the mitochondrion, proceeds into the cytoplasm, and finishes back in the mitochondrion. However, without porphobilinogen deaminase, a necessary cytoplasmic enzyme, heme synthesis cannot finish, and the metabolite porphyrin accumulates in the cytoplasm.

Additional factors must also be present such as hormones, drugs and dietary changes that trigger the appearance of symptoms. Symptoms of AIP may include abdominal pain, constipation, and muscle weakness.

Causes

Drug Causes

Treatment

A high-carbohydrate diet is typically recommended; in severe attacks, a glucose 10% infusion is recommended, which may aid in recovery. If drugs have caused the attack, discontinuing the offending substances is essential. Infection is one of the top causes of attacks and requires vigorous treatment. Pain is extremely severe and almost always requires the use of opiates to reduce it to tolerable levels. Pain should be treated early as medically possible due to its severity. Nausea can be severe; it may respond to phenothiazine drugs but is sometimes intractable. Hot water baths/showers may lessen nausea temporarily, but can present a risk of burns or falls.

Hematin and heme arginate are the drugs of choice in acute porphyria, in the United States and the United Kingdom, respectively. These drugs need to be given very early in an attack to be effective. Effectiveness varies amongst individuals. They are not curative drugs but can shorten attacks and reduce the intensity of an attack. Side effects are rare but can be serious. These heme-like substances theoretically inhibit ALA synthase and hence the accumulation of toxic precursors. In the United Kingdom, supplies of this drug are maintained at two national centers. In the United States, one company manufactures Panhematin for infusion. The American Porphyria Foundation has information regarding the quick procurement of the drug.

Patients with a history of acute porphyria are recommended to wear an alert bracelet or other identification at all times in case they develop severe symptoms: a result of which may be they cannot explain to healthcare professionals about their condition and the fact that some drugs are absolutely contraindicated. An attack of acute intermittant porphyria may be precipitated by one of the "four M's": medication, menstruation, malnutrition, maladies.

Patients who experience frequent attacks can develop chronic neuropathic pain in extremities as well as chronic pain in the gut. This is thought to be due to axonal nerve deterioration in affected areas of the nervous system. In these cases treatment with long-acting opioids may be indicated. Some cases of chronic pain can be difficult to manage and may require treatment using multiple modalities. Depression often accompanies the disease and is best dealt with by treating the offending symptoms and if needed the judicious use of anti-depressants.

Seizures often accompany this disease. Most seizure medications exacerbate this condition. Treatment can be problematic: barbiturates must be avoided. Some benzodiazepines are safe, and, when used in conjunction with newer anti-seizure medications such as gabapentin offer a possible regime for seizure control.

Urine from a person experiencing an acute attack will be red or "port wine" in color because of the presence of porphyrins. This condition is known as Porphyrinuria or Pyroluria.

Contraindicated medications

History of acute intermittent porphyria is considered an absolute contraindication to the use of the following medications:

Famous sufferers

One of the many hypothesized diagnoses of the artist Vincent van Gogh is that he and his siblings, particularly his brother Theo, suffered from AIP.[1] Another theorized sufferer was King George III of England, who even had a medallion struck to commemorate his "curing".

Cultural references

AIP makes an appearance on the television show House in season 1, episode 22 where Dr. House diagnoses his ex-wife's new husband with the disease.

It also makes an appearance on the television show Scrubs in season 4, episode 13 as a difficult to diagnose disease.

The TLC docudrama mini series, Mystery ER, features a landscaper with AIP who is repeatedly misdiagnosed.

See also

Template:Endocrine, nutritional and metabolic pathology

References

  1. Arnold, Wilfred N. Vincent van Gogh: Chemicals, Crises, and Creativity, Birkhãuser, Boston, 1992. ISBN 0-8176-3616-1.

de:Akute intermittierende Porphyrie


Template:WikiDoc Sources